earlier studies it is known that 9 -cy-D -arabinofuranosyladenine ((Y-araA) and 9-cY-D-arabinofuranosyl-8-azaadenine (cu-ara-8-azaA) have in vitro antiviral activity, are cytotoxic, and are metabolized in mammalian cells to the triphosphates. This study was designed to compare the in uiuo antiviral activities of these compounds and their loci of action with those of 9-j?-D-arabinofuranosyladenine (/3-araA). The latter compound selectively inhibits DNA synthesis in intact cells, and its triphosphate is a known inhibitor of DNA polymerases and ribonucleotide reductase. Whereas /?-araA was significantly effective in the treatment of systemic herpes simplex virus type 1 (HSV-1) infections in mice, cu-araA and a-ara-8-azaA were therapeutically ineffective. cu-AraATP at a concentration of -1 mM did not inhibit (1) DNA polymerases present in crude extracts of cultured H.Ep.-2 cells; (2) DNA polymerases present in extracts of KB cells; (3) partially purified DNA polymerase-cufrom mouse embryo cells; or (4) DNA polymerases induced by HSV-1 and HSV-2. DNA polymerasej3 from mouse embryo cells was inhibited to a small extent by 10e4M cY-araATP. In contrast, all of these enzymes were inhibited by /3-araATP at a concentration of 10m5M (as shown in these or in earlier studies). The reductions of CDP and UDP by ribonucleotide reductase from L1210 cells were not inhibited by LYaraATP (-10e3M), whereas /3-araATP produced 70-80 per cent inhibition at this concentration. In cultured H.Ep.-2 cells, a+ara-8-azaA inhibited the incorporation of thymidine, uridine, and formate into macromolecules, but it was without effect on the incorporation of adenine and hypoxanthine, and produced marginal inhibition of the incorporation of leucine. a-Ara-8-azaA produced a dose-dependent inhibition of the accumulation of ['"Cl formyl-glycinamide ribonucleotide in H.Ep.-2 cells treated with azaserine and ['"Cl formate. These results indicate that the cY-nucleosides inhibit nucleic acid synthesis by mechanisms different from those of /3-araA.
We have reported earlier that 9-cY-o-arabinofuranosyladenine (cu-araA)Q and 9-a-D-arabinofuranosyl-8-azaadenine (cu-ara-&azaA) exert significant antiviral effects against herpes simplex virus type 1 (HSV-1) in vitro [l] and that these compounds are cytotoxic to cultured mammalian cells [2] . IXAra-&azaA is a substrate for adenosine kinase and its principal metabolite in cell culture is cu-ara-8-azaATP [2] . a-AraA is also anabolized in mammalian cells to the triphosphate [3] . 9-@-D-Arabinof'uranosyladenine (PAraA) is important both as an antiviral agent and as an antitumor agent, but its antitumor activity is limited by its ready deamination so that it is active only in the presence of inhibitors of adenosine deaminase (ADA) [4, 5] . cu-AraA and Lu-ara-&azaA are resistant to attack by ADA 121; hence, if Lu-araA should have sites of action similar 5 Abbreviations: cu-AraA, 9-cu-D-arabinofuranosvladenine; cu-ara-&azaA, 9-a-D-arabinofuranosyl-8-azaadenine; /%araA, 9-@-arabinofuranosyladenine;
HSV-1, herpes simplex virus, type 1; HSV-2, herpes simplex virus, type 2; and ADA, adenosine deaminase.
to those of /3-araA, it would be the preferred agent because it would not be necessary to use it in combination with an ADA inhibitor. It was therefore desirable to compare the biological activities and the biochemical properties of the a+arabinosyl compounds with those of /3-araA. We report here three such studies. The first is a quantitative evaluation of a-araA and a-arad-azaA for in vivo therapeutic efficacy against lethal HSV-1 infections in mice. The second is a comparison of the effects of cu-araATP and @-araATP on ribonucleotide reductase and on cellular and HSV-induced DNA polymerases. These enzymes were chosen because each was known to be inhibited by ParaATP . The third was a study in cultured cells of the metabolic effects of cu-ara-&azaA, which was selected for study over a+ araA because it is more toxic and because it was the compound with which we conducted earlier metabolic studies [2] .
While this work was in progress, Miiller et al. [3, 11, 12, 14] , using a sample of a+araATP from the same batch utilized herein, reported it to be an effective inhibitor of DNA polymerase-Lu and therefore similar in mode of action to @araATP. Our results, some of which have been reported in preliminary form [15] , differ from those of Miiller and his associates and reopen the question as to the L. LEE BENNE~ et al.
mechanisms
of action of the cY-arabinosyl compounds.
MATERIALS AND METHODS

Compounds
@-AraA and cY-ara-8-azaA were synthesized in our laboratory by procedures described earlier [16] . oAraA was converted to a+araATP by Terra Marine Bioresearch, La Jolla, CA. The product was analyzed in our laboratories by high pressure liquid chromatography (h.p.1.c.) with a Waters Associates (Milford, MA) model 202 apparatus. Chromatography was performed with a Partisil-10 SAX anion exchange column (Whatman, Inc., Clifton, NJ), 4.6 mm i.d. x 25 cm. Elution was achieved with a linear gradient of 5mM NHdHzP04, pH 2.8, to 750 mM NHdHzPOd, pH 3.7, at a flow rate of 2 ml/ min, and detection of eluted materials was accomplished by measurement of U.V. absorption at 254 nm. Integrations of peak areas were made with a Hewlett-Packard model 3380-A digital electronic integrator, and quantitations were achieved using peak area-nmole relationships derived from determinations of known nucleotides. Three peaks were obtained. The principal peak, which eluted with a retention time indicative of a triphosphate and about the same as ATP (34 min), amounted to 64-67 per cent of the sample. There were two smaller peaks with retention times close to those of ADP (15-17 min); these were presumed to be isomeric diphosphates (cL-araADP, Lu-araA-3',5'-diphosphate, or a+araA-2',5'-diphosphate).
To confirm that all of the phosphates present were derivatives of a-araA, a sample of cY-araATP was treated overnight with crude snake venom (Ross Allen's Reptile Institute, Silver Springs, FL) and then chromatographed on a PBondapak
Crs column (Waters Associates), 3.9 mm i.d. x 30cm. The solvent consisted of HrG-acetonitrile (95:5, v/v) and the flow rate was 0.8 ml/min. Detection of peaks was accomplished as described above for ion exchange chromatography. A single peak was obtained with a retention time (14 min) the same as that of Lu-araA. We have shown earlier that this procedure gives a good separation of the a+ and panomers of ara-8-azaA [2] .
PAraA and azaserine were obtained from the and Lord4 for each compound. Twenty untreated virus-infected mice served as the virus control group. Ten uninfected animals were sham-injected i.p. with 0.2 ml of the virus diluent alone (no virus), and ten uninfected animals were sham-injected i.p. on the q.d. l-7 day schedule with the drug diluent alone (no drug). In addition, a group of ten uninfected, untreated mice was held as normal controls. /3-AraA was employed as a positive control drug and was concomitantly administered i.p. to groups of ten virus-infected and ten uninfected animals on the same schedule (q.d. l-7 days) as the o-nucleoside analog-treated groups. The animals were observed daily for deaths and weight loss over a 21-day observation period, and results were expressed in terms of the percentage of survivors in the virus-infected, drug-treated groups compared to that observed in the virus-infected control (untreated) group, or in terms of the mean survival time of animals dying on or before day 21 postinfection in the drug-treated groups compared to that observed in the control group.
All data were subjected to statistical evaluation to determine the significance of differences observed. The Chi-square test was used to compare the mortality of control and drug-treated mice, while Student's t-test was employed to compare the differences in mean survival time of virus-infected control and drug-treated animals. A P value of < 0.05 was considered indicative of a statistically significant difference.
Assays of DNA polymerases
Effects of (Y-and /3-araATP were determined on mixed DNA polymerases present in crude supernatant fractions from cultured H.Ep.-2 cells, on partially purified DNA polymerase-a and DNA polymerase+l from mouse embryo cells, and on DNA polymerases present in extracts from whole HSV-infected and uninfected KB cells. For preparation of the crude polymerases from H.Ep.-2 cells, the cells were homogenized in a Potter-Elvehjem glass homogenizer with a Teflon pestle and the homogenate was centrifuged at 100,OOOg; the supernatant fraction was used as the enzyme fraction. Polymerase activity was determined by incubating the enzyme with ['4C]dTTP, unlabeled dCTP, dATP, and dGTP, and primertemplate DNA, as described in Fig. 1 . Polymerase activity was measured by the incorporation of label into acid-insoluble material determined by the method of Bollum [18] . Studies with the purified polymerase-cu and /3 from mouse embryo cells were performed in a manner similar to that described in Table 2 .
Preparation of uninfected and HSV-infected KB celki. Uninfected KB cells were grown in suspension culture as described previously [ 191. Cells were harvested at a density of approximately 500,000 cells/ml by low-speed centrifugation, washed twice by suspension and centrifugation in cold 20 mM Tris-HCl (pH 7.5) containing 150 mM KCl, frozen rapidly by immersion in liquid nitrogen, and stored at -76".
To obtain cells infected with HSV, nearly confluent roller cultures of KB cells were exposed to either the HF strain of HSV-1 or the X-79 strain of HSV-2 at an input multiplicity of 5 plaque-forming units/cell. After a l-hr period of adsorption, virus growth medium (Eagle's minimum essential medium supplemented with Hanks' salts, 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 1.2 mM arginine, 100 units/ml penicillin G, 50 yglml streptomycin sulfate, and 10% unheated calf serum) was added. Incubation at 37" was allowed to proceed until 18 hr post-infection, when HSV-induced DNA polymerase activity had attained a maximum level. Infected cells were detached by agitation (HSV-1) or scraping (HSV-2), collected, washed, and stored in the same manner as described for uninfected cells.
Preparation of whole KB cell extracts. Extracts were prepared from whole uninfected and HSVinfected KB cells using the method of Powell and Purifoy [20] . All steps were conducted at O-4". In brief, cells were thawed, suspended in hypotonic buffer, and disrupted ultrasonically. The sonically treated suspension was made 1.7 M in KCl, left on ice for 60 min, clarified by ultracentrifugation, and dialyzed extensively against 50mM Tris-HCl (pH 7.5) containing 0.5 mM dithiothreitol, 0.2% Nonidet P-40, and 20% glycerol. The precipitate that formed during dialysis was removed by ultracentrifugation, and the supernatant liquid, which contained most of the DNA polymerase activities detectable in the unclarified sonically treated suspension, was divided into small aliquots and stored at -76".
KB cell and HSV-specific DNA polymerase assays.
Polymerase-specific reaction mixtures were modifications of those developed by Weissbach and associates [21, 22] . The basic reaction mixture for assay of both cl-polymerase and Ppolymerase activities in extracts from uninfected KB cells consisted of: 50 mMTris-HCl (pH 8.5), 7.5 mM MgC12,500 ,ng/ml bovine serum albumin, 750 ,ug/ml activated calf thymus DNA, 25pM [3H]dATP (sp. act. 50-200 cpm/pmole) and dCTP, dGTP, and dTTP at 100 PM each. Dithiothreitol at a final concentration of 0.5 mM was included in the cu-polymerase assay. To distinguish a+polymerase from P-polymerase, dithiothreitol was omitted and N-ethylmaleimide and KC1 were added to final concentrations of 5 mM and 100 mM respectively. Separation of cu-polymerase and ppolymerase activities into characteristic peaks on sucrose density gradients [23] established that KB a+polymerase did not react in the fipolymerase assay. KB Ppolymerase reacted to a greatly diminished extent in the cl-polymerase assay. When extracts from uninfected cells were assayed using the cu-polymerase assay, however, the contribution of fipolymerase to total activity detected was negligible.
HSV-specific DNA polymerase activity was assayed in extracts from HSV-infected cells, using a reaction mixture that contained 100 mM Tris-HCl (pH 8.0), 2 mM MgC12, 0.5 mM dithiothreitol, and 120mM KrS04. Bovine serum albumin, activated calf thymus DNA, [3H]dATP, dCTP, dGTP and dTTP were all present at the same final concentrations employed for Lu-polymerase and Ppolymerase assays. The reaction mixture was specific for the viral DNA polymerase: optimal activity was obtained in assays of extracts from HSV-infected cells, but under identical assay conditions only an extremely low level of activity was detected in an extract from uninfected cells. The residual activity may have been due to cellular y-polymerase [24] . All assays were incubated at 37" for 15 min. Acid-precipitable radioactivity was quantitated as described previously [ 131.
Studies with ribonucleotide reductase
Ribonucleotide reductase was prepared from cultured H.Ep.-2 cells essentially as described in published work [25] . The fraction used was that precipitated by 2540% ammonium sulfate. Conditions of the assay are given in Table 3 .
Nucleic acid synthesis in H. Ep. -2 cells,
H.Ep.-2 cells were grown in suspension culture in SRI-14 medium [26] . To logarithmically growing cell cultures (-2 x lo5 cells/ml) was added a-ara-&azaA at the desired concentration, followed 1 hr later by the labeled precursors at the concentrations shown in the legend to Table 4 . The cells were harvested 4 hr after addition of the labeled precursors and were washed free of medium with 0.85% NaCl solution. Soluble materials were removed by extraction with boiling 80% ethanol. The residue was extracted with hot 10% NaCl solution; crude polynucleotides (DNA + RNA) were precipitated from the extract by the addition of 4 vol. of ethanol. The polynucleotides were redissolved in water and the concentration was determined by measurement of U.V. absorbance at 254 nm. Portions of this solution were pipetted into vials for determination of radioactivity in a Packard TriCarb liquid scintillation spectrometer. These procedures have been described in detail elsewhere [27] .
De novo synthesis of purine nucleotides
The effects of o-ara-8-azaA on synthesis of purine nucleotides de novo were determined by a previously described modification [28] of the method of LePage and Jones [29] , which involves measurement of the inhibition of synthesis of [14C]formylglycinamide ribonucleotide in cells grown in the presence of azaserine and [r4C]formate. Additional details are given in Table 5 . Although ParaA produced a highly significant antiviral effect against HSV-1 in vivo, treatment with t Only animals dying on or before day 21 after virus inoculation were considered. $ Probability (P) that the observed increase in the number of survivors was due to chance < 0.0005 (y-test). 9 Probability (P) that the observed increase in the mean survival time was due to chance < 0.005 (Student's r-test). to 4 x 10m4M), which also showed no inhibition of polymerase activity.
RESULTS
Lack of in vivo
either o-araA or a-ara-&azaA was without therapeutic benefit. /3-AraA reduced the mortality from 90 per cent in the untreated, virus-infected control group to O-10 per cent in the virus-infected, drugtreated groups (Table 1 ). In addition, /3-araA at 500 mgakg-'*day-' significantly increased the mean survival time of dying animals from 7.9 days in the control (untreated) group to 15.0 days. No such increases were observed in the numbers of survivors or in the mean survival times of HSV-infected mice treated with rw-araA or a+ara-8-azaA.
Effects of nucleotide analogs on DNA polymerases
The effects of (E-and /3-araATP on mixed DNA polymerases present in crude supernatant fractions of H.Ep.-2 cells are shown in Fig. 1 . a-AraATP was non-inhibitory at concentrations up through 0.7 x 10A3M, the highest concentration assayed. /?-AraATP was inhibitory at a concentration of 1 x 10s5M, and increased concentrations gave proportionately increased inhibitions. Table 2 shows the effects of the anomeric triphosphates on the polymerases from mouse embryo cells. PAraATP inhibited both polymerases to about the same degree, and significant inhibition was produced by a concentration of 1 x lo-'M. a-AraATP did not inhibit DNA polymerase-a and produced a small inhibition of DNA polymerasej3 at a concentration of 0.7 x 10-4M. Figure 2 illustrates the effects of a cu-araATP on DNA polymerases in whole cell extracts prepared from uninfected or HSV-infected KB cells. The concentrations of cu-araATP employed ranged from 4 x 10e6 to 1.8 x 10W4M. The ratio of cu-araATP concentration to dATP concentration (inhibitor: substrate or I/S ratio) thus varied from 0.16: 1 to 7.2:1 (approximately 50-fold). In an extract from uninfected cells, neither a-polymerase nor /I-polymerase was affected significantly by @-araATP at the tested concentrations.
Activity in the presence of o-araATP was never less than 93 per cent nor more than 103 per cent of control activity. When extracts from HSV-l-or HSV-Zinfected cells were assaved under conditions specific for HSV-induced DNA polymerase, a+araATP appeared to be slightly inhibitory. At the highest cu-araATP concentration, activity was reduced to about 74 per cent of control. Under identical assay conditions, however, (YaraATP failed to inhibit activity in a preparation of HSV-1 DNA polymerase which had been partially purified by chromatography on DEAE-cellulose (data not shown).
In contrast to u+araATP, f3-araATP is a potent inhibitor of KB cell cu-polymerase and the HSV-1 DNA polymerase; KB cell Bpolymerase is considerably less sensitive [13] . In the current study, p araATP at an I/S ratio of 7.2: 1 (corresponding to the highest I/S ratio of o-araATP tested) reduced KB a-polymerase activity to approximately 7 per cent of conrol and HSV-1 DNA polymerase activity to approximately 2 per cent of control (data not shown). As indicated in Fig. 2 , ParaATP was also a strong inhibitor of virus-specific DNA polymerase activity in an extract from HSV-Zinfected KB cells; at an I/S ratio of 8 : 1, approximately 2 per cent of control activity remained.
Effects of nucleotide analogs on ribonucleotide reductase
As shown in Table 3 , /%araATP at a concentration of 5 x 10e5M inhibited the reduction of CDP and at a concentration of 5 x 10e4M inhibited the reduc- Table 2 * Effects of (Y-and BaraATP on the activities of partially purified mouse embryo cell DNA polymerase-cy and -/l preparations were determined by incubating each of the enzymes with the nucleotide analogs for 30 min at 37" in a reaction mixture (100 ~1) containing 20 PM ['HIdTIP (2.5 @i/l0 fl, -2000 dpm/pmole) as substrate; 2Opg activated (nicked) calf thymus DNA as primer-template; 20 PM dATP; 1.0 mM dCTP; 1.0 mM dGTP; 15 PM NaF; 5 mM dithiothreitol; 50 mM KCI; 0.8 mM MgClr; and 50 mM Tris-HCI buffer, pH 8.0. All tubes were held in an ice bath at 4" while additions were made. The reaction was initiated by the addition of the [3H]dTTP with immediate transfer to a 37" water bath. To terminate the reaction, 0.5 ml of a 0.1 M sodium pyrophosphate solution and 50 fi of carrier RNA (yeast tRNA, stripped; 4 mg/ml) was added to each tube. After thorough mixing, 0.5 ml of a cold 25% TCA solution was added to each tube and the contents were mixed again. Precipitates were allowed to form for at least 15 min at 4" before collection of samples on Millipore Celotate filters (25 mm), premoistened with cold 5% TCA, using a Millipore model 3025 Sampling Manifold and vacuum pump. Samples were washed six times with ice-cold 5% TCA and dried under an infrared heat lamp. The dried filters were then transferred to counting vials containing 0.2 ml distilled water and solubilized with 1.0 ml NCS Solubilizer (AmershamBearle, Arlington Heights, IL) by heating in an oven at 40-50" for 30 min. A toluene-base scintillation mixture was added to each vial and the radioactivity was measured in a Packard liquid scintillation counter. After incubation for 30 min at 37", the reaction was stopped by rapid heating to boiling for 2 min. Protein was removed by centrifugation; to the supernatant fraction was added crude snake venom (1 mg), alkaline phosphatase (0.2 unit), and deoxycytidine or deoxyuridine (50 pg). After incubation at 37" for 90 min, the reaction mixture was subjected to chromatography for separation of deoxycytidine or deoxyuridine. Areas containing these nucleosides were cut out and assayed for radioactivity. For CDP, values are the average of two experiments; for UDP, the results are for a single experiment. These procedures are described in detail elsewhere [25] . * cY-Ara-8-azaA was added to proliferating suspension cultures 1 hr before the addition of the labeled precursors, each of which was present at a concentration of 0.0385 PCilml. The micromolar concentrations of the individual precursors were: formate, 38; hypoxanthine, 0.79; adenine, 2.4; thymidine, 0.67; uridine, 0.69; and leucine, 2.3. The ceils were harvested 4 hr after addition of the labeled compounds, and the polynucleotides were isolated and assayed as described in the text. Results are for duplicate assays in a single experiment.
tion of UDP. acAraATP at a concentration of 0.7 x W3M was without effect on the reduction of CDP and was also without effect on the reduction of UDP at concentrations through 2 X 10T3M.
Metabolic effects of a-ara&azaA
When cu-ara-8-azaA was assayed for inhibition of incorporation of a number of precursors into polynucleotides, significant inhibitions were observed with formate, uridine, and thymidine, but not with adenine or hypoxanthine (Table 4 ). There was perhaps a small inhibition of the incorporation of leutine. A further study of the effects on utilization of [14C]formate is shown in Table 5 . a-Ara-S-azaA strongly inhibited the incorporation of formate into formylglycinamide ribonucleotide in cells that had been pretreated with azaserine.
DISCUSSION
The cytotoxicity and the antiviral and antitumor activities of /I-araA are associated with a selective inhibition of DNA synthesis, which is generally ascribed to inhibition of DNA polymerases [4, 5, 11] . Ribonucleotide reductase from some sources is also highly sensitive to ParaATP [6, 9, 30] , and its inhibition may contribute to the effects of araA on DNA synthesis. The results of the present study show that cu-araATP at concentrations in the mM range did not inhibit ribonucleotide reductase from H.Ep.-2 cells; DNA polymerases from H.Ep.-2 cells, KB cells, or mouse embryo cells; or DNA polymerases from HSV-1 or HSV-Zinfected cells. All of these enzymes were inhibited by ParaATP at a concentration of 5 x lo-'M or lower. Therefore, if DNA polymerases and ribonucleotide reductase are the primary sites of action of @-araA, it would appear that o-araA and /3-araA do not inhibit cell proliferation and virus replication by the same mechanism. In addition to the results reported here, Derse and Cheng [31] , using a sample of cu-araATP from the same batch used in this study, found no inhibition of highly purified DNA polymerases-cu and fi from HeLa cells. In contrast, Mtiller and his associates [3, 11, 12, 14] , also using a sample of cu-araATP obtained from us, reported that it was as effective ' cells in 100 ml of medium) asaserine was added to a concentration of 58pM, followed 30 min later by cu-ara-8-azaA. Thirty minutes after addition of nucleoside, 25 @i (3.8 pmoles) of sodium [14C]formate was added. Two hours after addition of labeled formate, the cells were harvested and assayed by paper chromatography and autoradiography (see text). The formylglycinamide derivatives include the ribonucleotide, the ribonucleoside, and ribonucleoside polyphosphates.
Results are for duplicate assays of a single experiment.
as EaraATP, or more so, as an inhibitor of DNA polymerase-n from rabbit kidney cells. We cannot explain this conflicting result from Miiller's laboratory other than to speculate that it may be due to a peculiarity of the rabbit kidney enzyme or may reflect some differences in conditions of assay. The bulk of the evidence, consisting of observations in three different laboratories with polymerases from four different types of cells, would appear to be against inhibition of DNA polymerases being a site of action of cu-araA. It is to be noted that Mtiller et al. found with HSV-2, as did we with both HSV-1 and HSV-2, that e+araATP did not inhibit the virus-specific polymerase [14] .
Study of the effects of a-ara-&azaA on the incorporation of precursors into macromolecules ( Table  4) showed inhibition of utilization of formate, thymidine, and uridine, with formate representing the strongest inhibition.
Further study with formate (Table 5) showed that a-ara-&azaA inhibited an early site on the pathway of synthesis of purine nucleotides, an action produced by many other purine and nucleoside analogs [28, 29] . It may be, then, that inhibition of DNA and RNA synthesis, as measured by utilization of thymidine and uridine, simply reflects inhibition of synthesis of purine nucleotides required for RNA and DNA synthesis. These results with cu-ara-&azaA differ from those of Miiller et al. [3] with o-araA. These investigators found cY-araA to inhibit thymidine incorporation selectively and to be incorporated in small amounts into DNA of L5178Y cells, In contrast, we failed to detect incorporation of [8-14C] -(u-ara-8-azaA into polynucleotides [2] . Thus, although it would be expected that such closely related compounds as Lu-araA and its 8-aza analog would have the same mechanism of action, our results with a-ara-8-azaA, unlike those of Miiller et al. with tr-araA, provide no evidence for selective effects on DNA synthesis.
These studies have also demonstrated the failure of these cY-arabinosyl compounds to inhibit lethal HSV-1 infections in mice at nontoxic doses, despite the earlier finding of antiviral activity in vitro [l, 321 .
The fact that this study has failed to reveal common sites of action for BaraA and cY-araA (or Lu-ara-8-azaA) raises anew the question as to the biochemical bases for the cytotoxicity of these cY-nucleosides. Since nucleosides in the "unnatural" cL-configuration are generally considered to be biologically inert, the mechanisms of action of the cu-arabinosyl derivatives are of some importance for an understanding of the relationship of structure to the biological activities of nucleoside analogs. Although the results reported herein and in our earlier study [2] do not define the mode of action of a+ara-8-azaA, they are consistent, as far as they go, with this agent functioning as a ribonucleoside analog, rather than as a deoxyribonucleoside analog; thus, it is a good substrate for adenosine kinase [2] and a moderately good inhibitor of purine synthesis de nova (Table 5) .
